New Quit-Smoking pill shows promise in major trial
NCT ID NCT05206370
Summary
This study tested whether a medication called cytisinicline could help adults quit smoking. Nearly 800 daily smokers who had previously tried to quit took either the medication or a placebo pill for 6 or 12 weeks, along with behavioral support. Researchers measured how many people successfully stopped smoking and stayed smoke-free for up to 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accel Research Sites - DeLand Clinical Research Unit
DeLand, Florida, 32720, United States
-
Affinity Health Corp
Oak Brook, Illinois, 60523, United States
-
Alliance for Multispecialty Research, LLC
Fort Myers, Florida, 33912, United States
-
Aventiv Research Inc
Columbus, Ohio, 43212, United States
-
Clinical Research Associates, Inc.
Nashville, Tennessee, 37203, United States
-
Global Medical Institutes LLC; Princeton Medical Institute
Princeton, New Jersey, 08540, United States
-
Health Research of Hampton Toads, Inc
Newport News, Virginia, 23606, United States
-
Intend Research
Norman, Oklahoma, 73069, United States
-
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216, United States
-
MediSphere Medical Research Center, LLC
Evansville, Indiana, 47714, United States
-
Trial Management Associates, LLC
Wilmington, North Carolina, 28403, United States
-
Velocity Clinical Research, Inc.
Cleveland, Ohio, 44122, United States
Conditions
Explore the condition pages connected to this study.